There are several investigators that have examined α-synuclein levels in the brain and CSF of patients with Alzheimer’s disease and primary α-synucleinopathies such as Parkinson’s disease and dementia with Lewy bodies [374,375,376]. The gene discussed is SNCA; the disease is Parkinson disease.